Development of de novo HLA donor specific antibodies (HLA-DSA), HLA antibodies (HLA-Ab) and allograft rejection post blood transfusion in kidney transplant recipients.

CONCLUSION: Blood transfusion under strong immunosuppressive cover within a one-week post-operative period is safe with no significant association with the development of de novo HLA-DSA, HLA-Ab or clinical rejection. PMID: 32327243 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32327243?dopt=Abstract

Source: Human Immunology - April 19, 2020 Category: Allergy & Immunology Authors: Jalalonmuhali M, Carroll RP, Tsiopelas E, Clayton P, Coates PT Tags: Hum Immunol Source Type: research